-
miR-200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
Study
EGAS00001002184
-
The genomic landscape of cutaneous squamous cell carcinoma from immunosuppressed and immunocompetent patients reveals common drivers and a novel mutational signature associated with chronic azathioprine exposure
Study
EGAS00001002612
-
Dynamics of neoantigen landscape during immunotherapy
Study
EGAS00001002704
-
Colorectal adenomas, NKI-AvL TGO series Stool-Proteomics
Study
EGAS00001002953
-
Utility of ctDNA to support patient selection for early phase clinical trials: The TARGET Study
Study
EGAS00001003407
-
Exome sequencing of synchronous colorectal cancers
Study
EGAS00001003474
-
DNA Methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load
Study
EGAS00001003731
-
Whole-exome sequencing and microRNA profiling predicted relapse risk of stage I lung adenocarcinomas
Study
EGAS00001004461
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551
-
Mutations in the RAS/MAPK pathway drive replication repair deficient hypermutated tumors and confer sensitivity to MEK inhibition
Study
EGAS00001005008
-
Engineering large chromosomal deletions by CRISPR-Cas9
Study
EGAS00001005134
-
Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing - NGS targeted capture control cohort
Study
EGAS00001005325
-
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Study
EGAS00001005982
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Molecular Profiling and Sequential Somatic Mutation Shift in Hypermutator Tumors Harboring POLE Mutations
Study
JGAS000130
-
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with Constitutional Mismatch Repair Deficiency
Study
EGAS00001007660
-
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways
Study
EGAS00001006631
-
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia
Study
EGAS00001004407
-
Genome-wide discovery of somatic coding and regulatory variants in Diffuse Large B-cell Lymphoma
Study
EGAS00001002936
-
Spatial genomic heterogeneity in multiple myeloma revealed by multi- region sequencing
Study
EGAS00001002111
-
Loss of Epigenetic Barrier is Required for Enhancer Hijacking-Mediated Oncogenic Transcription
Study
EGAS00001006140
-
Immune trajectory of response and adverse effect in immunotherapy-treated hepatocellular carcinoma
Study
EGAS00001004843
-
Adult granulosa cell tumor WGS data cohort with corresponding reference germline WGS data
Study
EGAS00001004249
-
Longitudinal Single-Cell Profiling Reveals Molecular Heterogeneity and Tumor-Immune Evolution in Refractory Mantle Cell Lymphoma
Study
EGAS00001005019
-
A Genome-wide Association Study (GWAS) of Risk for Osteosarcoma
Study
phs000734
-
GeneScreen, a Population Based, Targeted Genomic Screening Study
Study
phs001817
-
Metastatic Colorectal Adenocarcinoma Tumor Purity Assessment from Whole Exome Sequencing Data
Study
phs003059
-
Treatment stratification and biomarker validation using patient-derived head and neck cancer organoids
Study
EGAS00001007076
-
RB Loss in Resistant EGFR Mutant Lung Adenocarcinomas that Transform to Small Cell Lung Cancer
Study
EGAS00001001102
-
MYO5B mutations in Pheochromocytoma/Paraganglioma promote cancer progression
Study
EGAS00001003991
-
Comprehensive genomic analysis of colorectal cancer with microsatellite instability
Study
JGAS000113
-
Analysis of mutational and proteomic heterogeneity of gastric cancer to monitor post-treatment tumor burden using circulating tumor DNA
Study
JGAS000231
-
Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling
Study
JGAS000243
-
Molecular Evolution of Cancer
Study
phs001255
-
Whole genome sequencing informs treatment decision of end-stage metastatic cutaneous angiosarcoma in a patient with Xeroderma Pigmentosum
Dataset
EGAD00001004786
-
Spatial whole exome sequencing of metastatic melanoma
Dataset
EGAD00001005819
-
MutWP5: CRUK Mutographs of Cancer: Lung: PD38234 (Targeted) (2020-01-29)
Dataset
EGAD00001005925
-
Dataset for soft_tissue_tumor-WHOLE_GENOME
Dataset
EGAD00001008900
-
Whole genome sequencing data of high-grade serous ovarian cancer samples (set 3)
Dataset
EGAD00001009888
-
Clonal architecture and genomic features of smoking versus non-smoking oncogene-driven East-Asian non-small cell lung cancer
Study
EGAS00001006942
-
Cylindromas_sun_protected_and_exposed
Study
EGAS00001002521
-
Amplicon_based_sequencing_of_drug_resistant_lung_cancer_cell_lines
Study
EGAS00001001675
-
Imaging metabolic heterogeneity in breast cancer using hyperpolarized 13C-MRI
Study
EGAS00001004118
-
Whole-genome sequencing on hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution
Study
JGAS000190
-
Childhood Cancer Data Initiative (CCDI): Clonal Evolution During Metastatic Spread in High-Risk Neuroblastoma
Study
phs003111
-
CALGB/SWOG 80405: Genome-Wide Association Study of Patients with Advanced or Metastatic Colorectal Cancer Treated with First-Line Chemotherapy Combined with Cetuximab and/or Bevacizumab
Study
phs003428
-
Genomic profiling of paediatric high grade gliomas from the HERBY clinical trial
Study
EGAS00001002328
-
Exome Sequencing to Define the Landscape of Plasma Cells in Systemic Light chain Amyloidosis
Study
EGAS00001001418
-
Liver biopsy derived induced pluripotent stem cells provide an unlimited supply for the generation of patient-specific hepatocyte-like cells
Study
EGAS00001002676